A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of sub-Saharan West African Ancestry

Trial Identifier: D6800C00002
Sponsor: AstraZeneca
Collaborator:
Parexel International
NCTID:: NCT05351047
Start Date: April 2022
Primary Completion Date: July 2023
Study Completion Date: July 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225